Skip to content

Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study

Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00611078
Enrollment
56
Registered
2008-02-08
Start date
2004-09-30
Completion date
2011-01-31
Last updated
2011-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soft Tissue Sarcoma

Keywords

Soft Tissue Sarcoma, environment, pollutants, 04-088

Brief summary

The purpose of this study is to assess the feasibility of conducting a large hospital based case control study of the role of dioxins and dioxinlike polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs).

Interventions

None listed

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with Soft tissue sarcoma at MSKCC are eligible for this study if they meet the following criteria: * Between 18 and 79 years of age * were diagnosed within the previous 6 months with primary soft tissue sarcoma of one of the following histologic subtypes: liposarcoma, leiomyoscaroma, MFH, or synovial sarcoma * are enrolled in protocol 02-060 (Novel Biochemical and Molecularr Determinants for Soft Tissue Sarcoma; PI, Dr. Samuel Singer) * controls will be eligibile for this study if they meet the following criteria * are b/w 18-79 years of age * have no prior history of cancer (other than non melanoma skin cancer)

Exclusion criteria

* Individuals will be excluded if they * are unable to sign informed consent for medical or other reasons * do not speak english

Design outcomes

Primary

MeasureTime frame
enrollment of 60 participantsConclusion of the study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026